CD4 and tuberous sclerosis: Experiments to determine how CD4+ T cells mediate inhibition of TSC tumor growth are ongoing as are experiments to determine whether antibodies mediate inhibition of TSC tumor growth by neutralization of inhibin-α or by complement-dependent cytotoxicity.